iSTAR Medical SA applications

A comprehensive clinical trial program supports the development of MINIject^®, with positive combined results at two years from the STAR-I and STAR-II clinical trials shown below. ¹

There are a range of possible treatments for Glaucoma, depending on the severity of disease progression. Treatments aim to reduce eye pressure by aiding fluid to drain from the eye. Physicians decide which treatment is best for a patient’s individual condition.